| Name | Title | Contact Details |
|---|
Paragon Medical is a turnkey supplier of world-class solutions for cases and trays, surgical instrumentation (reusable and single-use), implantable components, and design & development services to the medical device marketplace.
LaserStim is a Plano, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tower Health is a regional integrated healthcare system that offers leading-edge, compassionate healthcare and wellness services to communities in Berks, Chester, Montgomery, and Philadelphia Counties. With nearly 12,000 team members, Tower Health consists of Reading Hospital in West Reading; Chestnut Hill Hospital in Philadelphia; Phoenixville Hospital in Phoenixville; Pottstown Hospital in Pottstown; and St. Christopher`s Hospital for Children, a partnership of Tower Health and Drexel University in Philadelphia. It also includes Reading Hospital Rehabilitation at Wyomissing; Reading Hospital School of Health Sciences in West Reading; home healthcare provided by Tower Health at Home; TowerDirect ambulance and emergency response; Tower Health Medical Group; and a network of 25 urgent care facilities across the Tower Health service area.
Quick Med Claims (QMC) is a nationally recognized leader in emergency medical transportation billing and reimbursement. QMC is committed to providing services in a manner that ensures compliance with all applicable billing and reimbursement regulations, while maximizing the capture of allowable reimbursement for each client. The commitment to adherence to both of these principles makes QMC the partner of choice for emergency medical transportation providers. The company experience is deep enough and broad enough to ensure a high level of quality in all aspects of the service, while maintaining a manageable number of clients to provide individual attention for each. This balance has been the hallmark of the QMC approach since the foundation of the company. QMC is committed to the success of the emergency medical transportation programs that it supports and the existing client base has benefited from this commitment. QMC leadership works closely with client leadership to meet the strategic goals of the program and the sponsoring organizations.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).